evoke reiterates FY25E revenue growth guidance of 5-9%
evoke reiterates FY25E revenue growth guidance of 5-9%Source: Investing.com
Category: Investing News
أخبار الاستثمار والأسواق المالية من موقع Investing.com
ME Group shares rise after record H1 profit
ME Group shares rise after record H1 profitSource: Investing.com
NXP Semiconductors shares slip premarket after second-quarter revenue drops 6%
NXP Semiconductors shares slip premarket after second-quarter revenue drops 6%Source: Investing.com
Argentex Group announces CEO resignation as administration looms
Argentex Group announces CEO resignation as administration loomsSource: Investing.com
Centrica’s final Sizewell C deal is ‘attractive’, promises solid returns; stock up
Centrica’s final Sizewell C deal is ‘attractive’, promises solid returns; stock upSource: Investing.com
AstraZeneca to invest $50 billion in U.S. operations by 2030
AstraZeneca to invest $50 billion in U.S. operations by 2030Source: Investing.com
Ibex sells $1.5 billion stake in Pepkor as restructuring continues
Ibex sells $1.5 billion stake in Pepkor as restructuring continuesSource: Investing.com
BlackRock imposes restriction on use of company devices for China travel, Bloomberg News reports
BlackRock imposes restriction on use of company devices for China travel, Bloomberg News reportsSource: Reuters
Enagas reports 1H25 results in line with expectations
Enagas reports 1H25 results in line with expectationsSource: Investing.com
Diaceutics maintains FY targets with 22% revenue growth in H1
Diaceutics maintains FY targets with 22% revenue growth in H1Source: Investing.com
Contact us today to begin the process of documenting your financial transaction.
Official website:
www.taxtct.com
WhatsApp and direct call
+44 7480 219471
info@taxtct.com
جميع الحقوق محفوظة ©
All rights reserved ©